FR2829503B1 - Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih) - Google Patents

Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)

Info

Publication number
FR2829503B1
FR2829503B1 FR0210590A FR0210590A FR2829503B1 FR 2829503 B1 FR2829503 B1 FR 2829503B1 FR 0210590 A FR0210590 A FR 0210590A FR 0210590 A FR0210590 A FR 0210590A FR 2829503 B1 FR2829503 B1 FR 2829503B1
Authority
FR
France
Prior art keywords
hiv
analyzing
novel method
human immunodeficiency
phenotypic characteristics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0210590A
Other languages
English (en)
Other versions
FR2829503A1 (fr
Inventor
Francois Clavel
Fabrizio Mammano
Esther Race
Elisabeth Dam
Veronique Obry
Virginie Trouplin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioalliance Pharma SA
Original Assignee
Bioalliance Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0103970A external-priority patent/FR2816635A1/fr
Application filed by Bioalliance Pharma SA filed Critical Bioalliance Pharma SA
Priority to FR0210590A priority Critical patent/FR2829503B1/fr
Publication of FR2829503A1 publication Critical patent/FR2829503A1/fr
Application granted granted Critical
Publication of FR2829503B1 publication Critical patent/FR2829503B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0210590A 2001-03-23 2002-08-26 Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih) Expired - Fee Related FR2829503B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0210590A FR2829503B1 (fr) 2001-03-23 2002-08-26 Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0103970A FR2816635A1 (fr) 2000-11-10 2001-03-23 Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine (vih)
FR0210590A FR2829503B1 (fr) 2001-03-23 2002-08-26 Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)

Publications (2)

Publication Number Publication Date
FR2829503A1 FR2829503A1 (fr) 2003-03-14
FR2829503B1 true FR2829503B1 (fr) 2007-06-01

Family

ID=29404168

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0210590A Expired - Fee Related FR2829503B1 (fr) 2001-03-23 2002-08-26 Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)

Country Status (1)

Country Link
FR (1) FR2829503B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6103462A (en) * 1998-05-29 2000-08-15 Institut Pasteur Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
GB9909793D0 (en) * 1999-04-28 1999-06-23 Glaxo Group Ltd Improved assay and reagents therefor
CA2429073A1 (fr) * 2000-11-10 2002-05-16 Bioalliance Pharma Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine (vih)

Also Published As

Publication number Publication date
FR2829503A1 (fr) 2003-03-14

Similar Documents

Publication Publication Date Title
DE60208794D1 (de) 4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
HUP0301308A2 (hu) Emberi Papillomavírus-fertőzés gyógykezelése
DK0980203T3 (da) Antimikrobiel forebyggelse og behandling af humant immundeficiensvirus og andre infektiöse sygdomme
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
IL202249A (en) Nucleic Acids Encoders Human Immunodeficiency Strange Type 1 (HIV – 1) Group M Consensus Envelope Glycoproteins
CA2253490A1 (fr) Utilisation d'il-12 ifn-.alpha. pour le traitement de maladies infectieuses
EP1569652A4 (fr) Nucleosides n sp 4 /sp -acylcytosines pour le traitement d'infections virales
EA200000840A1 (ru) Антивирусные производные пиримидина
HK1074221A1 (en) Genotyping kit for diagnosis of human papilloma virus infection
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
DE60219005D1 (de) Feste pharmazeutische formulierung enthaltend modafinil
AU2305202A (en) Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv)
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
AU2002223052A1 (en) Novel method for analysing phenotypic characteristics of human immunodeficiency virus (HIV)
DE50015096D1 (de) Das genom des hiv-1 intersubtyps (c/b') und seine anwendungen
WO2002022076A3 (fr) Moyens et methodes de suivi d'une therapie antiretrovirale a base d'inhibiteurs de proteases et decisions d'orientation therapeutique dans le traitement du vih et du sida
FR2829505B1 (fr) Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
FR2829503B1 (fr) Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
FR2829501B1 (fr) Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
FR2829502B1 (fr) Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
ITTO20020284A0 (it) Procedimento per la sterilizzazione e la neutralizzazione di odori dell'aria.
EP0948967A3 (fr) Traitement d'une infection virale chez le porc
EP1407042A4 (fr) Dispositif et methodes de surveillance d'une therapie antiretrovirale inhibitrice de la protease et determination de decisions therapeutiques dans le traitement du vih/sida
GB0130947D0 (en) Improved sample preparation for the detection of infectious agents

Legal Events

Date Code Title Description
TQ Partial transmission of property
CL Concession to grant licenses
ST Notification of lapse

Effective date: 20121130